Health Catalyst (HCAT) Misses Q4 EPS by 40c

Health Catalyst (NASDAQ: HCAT) reported Q4 EPS of ($0.33), $0.40 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $79.6 million versus the consensus estimate of $80.68 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Meritage Homes (MTH) Reiterated at Market Outperform by Citizens: Stock up 24%
• CRISPR Therapeutics (CRSP) Reiterated at Market Outperform by Citizens
• Raymond James Downgrades Delta Air Lines (DAL) to Outperform